Company research / LXRX
Lexicon Pharmaceuticals, Inc. (LXRX)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Lexicon Pharmaceuticals, Inc. reported revenue of $49.80M. Revenue grew 60.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $41.47M.
Key ratios (year ended 2025-12-31)
-98.2%
Operating margin
-101.1%
Net margin
-46.8%
Return on year-end equity
60.2%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.